SecSonar.com

BioAtla, Inc. (BCAB)

BioAtla, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

BioAtla, Inc. (BCAB) is a Biotechnology company based in US with a market capitalization of $5M. Free cash flow was negative at -$48.2M. This page tracks BCAB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 61 employees · IPO Dec 16, 2020

Valuation

Valuation & price

$4.27 · as of May 17, 2026 · -93.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$61.00$32.16$3.33Jul 25Dec 25Jul 26Jul 7, 25$19.30Jul 9, 25$19.39Jul 11, 25$19.18Jul 15, 25$19.70Jul 17, 25$18.53Jul 21, 25$16.80Jul 23, 25$19.99Jul 25, 25$17.74Jul 29, 25$17.38Jul 31, 25$17.95Aug 4, 25$16.58Aug 6, 25$18.73Aug 11, 25$18.13Aug 13, 25$19.62Aug 15, 25$18.39Aug 19, 25$18.51Aug 21, 25$17.88Aug 25, 25$17.80Aug 27, 25$22.34Aug 29, 25$22.78Sep 3, 25$24.43Sep 5, 25$26.83Sep 9, 25$35.66Sep 11, 25$38.71Sep 16, 25$36.10Sep 18, 25$34.55Sep 22, 25$31.28Sep 24, 25$30.35Sep 26, 25$33.46Sep 30, 25$34.39Oct 2, 25$33.14Oct 6, 25$41.00Oct 8, 25$45.68Oct 10, 25$43.38Oct 14, 25$40.04Oct 16, 25$36.82Oct 21, 25$34.50Oct 23, 25$35.89Oct 27, 25$35.34Oct 29, 25$34.90Oct 31, 25$34.97Nov 4, 25$33.67Nov 6, 25$32.02Nov 10, 25$31.94Nov 12, 25$34.39Nov 14, 25$39.50Nov 18, 25$61.00Nov 20, 25$58.00Nov 25, 25$41.27Nov 28, 25$45.20Dec 2, 25$38.97Dec 4, 25$42.40Dec 8, 25$40.50Dec 10, 25$38.69Dec 12, 25$41.22Dec 16, 25$38.01Dec 18, 25$39.61Dec 22, 25$39.90Dec 24, 25$36.20Dec 29, 25$39.19Jan 2, 26$26.71Jan 6, 26$21.53Jan 8, 26$20.03Jan 12, 26$15.74Jan 14, 26$16.95Jan 16, 26$16.11Jan 21, 26$15.00Jan 23, 26$17.66Jan 27, 26$16.26Jan 29, 26$14.40Feb 2, 26$8.67Feb 4, 26$10.50Feb 9, 26$9.50Feb 11, 26$9.23Feb 13, 26$7.50Feb 18, 26$7.06Feb 20, 26$8.52Feb 24, 26$9.60Feb 26, 26$11.87Mar 2, 26$10.20Mar 4, 26$8.62Mar 6, 26$8.39Mar 10, 26$8.61Mar 12, 26$8.42Mar 17, 26$8.77Mar 19, 26$7.82Mar 23, 26$8.50Mar 25, 26$7.90Mar 27, 26$7.66Mar 31, 26$8.05Apr 2, 26$6.52Apr 7, 26$4.66Apr 9, 26$4.52Apr 13, 26$4.31Apr 15, 26$4.51Apr 17, 26$4.59Apr 22, 26$5.84Apr 24, 26$4.87Apr 28, 26$4.30Apr 30, 26$4.21May 4, 26$4.70May 6, 26$4.50May 8, 26$4.84May 12, 26$4.54May 14, 26$4.37May 18, 26$3.92May 20, 26$3.62May 22, 26$3.69May 28, 26$4.05Jun 1, 26$3.53Jun 3, 26$3.40Jun 5, 26$3.33Jun 9, 26$3.44Jun 11, 26$3.56Jun 15, 26$3.62Jun 17, 26$3.55Jun 22, 26$3.62Jun 24, 26$3.79Jun 26, 26$3.68Jul 2, 26$4.19
$3.3152-week range$61.00
Loading valuation history…

Fundamentals

Key fundamentals

$5M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$48.2M

Free cash flow (USD)

-$918K

Net debt

Net cash position

21.1%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$10.6MFY 2019$5.2MFY 2020$429.0KFY 2021$250.0KFY 2022$0.00FY 2023$0.00FY 2024$11.0MFY 2025$2.0M
$10.6M$2M

Free cash flow by year

2018 → 2025

FY 2018$-36.3MFY 2019$-11.2MFY 2020$-36.9MFY 2021$-63.1MFY 2022$-90.7MFY 2023$-104.1MFY 2024$-71.9MFY 2025$-48.2M
-$36.3M-$48.2M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 202491.6%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-6.18)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly report10-Q FiledMay 15, 2026Filing
  • Annual report10-K FiledApr 29, 2026Filing
  • 8-K eventMerger AnnouncementApr 2, 2026Filing
  • 8-K eventFinancial Results ReportedMar 31, 2026Filing
  • Annual report10-K FiledMar 31, 2026Filing

Questions

Frequently asked questions

What is BioAtla, Inc.'s market cap?

BioAtla, Inc. (BCAB) has a market capitalization of $5M.

What is BCAB's P/E ratio?

A meaningful P/E ratio is not available for BCAB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did BioAtla, Inc. last report earnings?

BCAB last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying BCAB stock?

SEC Form 4 filings show no open-market insider buys at BioAtla, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

PULM

Pulmatrix, Inc.

$5M

CLGN

CollPlant Biotechnologies Ltd.

$5M

ADXN

Addex Therapeutics Ltd

$5M

APM

Aptorum Group Limited

$5.3M

BRTX

BioRestorative Therapies, Inc.

$4.6M

BCDA

BioCardia, Inc.

$5.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.